Pharmaceutical and Biotechnology Market, By Product Type(Vaccines (Recombinant Vaccines, Conventional Vaccines, Recombinant Enzymes, Cell and Gene Therapies and Other Product Types) and Synthetic Immuno-modulators (Cytokines, Interferones, Interleukins and Tumor Necrosis Factor)),By Therapeutic Application (Oncology, Inflammatory and Infectious Diseases, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, Disease Prevention, Cardiovascular Diseases, Neurological Diseases and Other Diseases) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)Trends, Analysis and Forecast till 2029

Report Code: PMI88119 | Publish Date: March 2024 | No. of Pages: 181

Global Pharmaceutical And Biotechnology Market Overview

Introduction:

Biopharmaceuticals are medical drugs produced using biotechnology. Biopharmaceutical are proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) used for therapeutic or in vivo diagnostic purposes. The large majority of biopharmaceutical products are pharmaceuticals that are derived from life forms. Any biopharmaceutical product manufactured must satisfy the “current Good Manufacturing Practices” regulations of the FDA. Pharmaceutical biotechnology is a relatively new and growing field in which the principles of biotechnology are applied for the development of drugs.

Increasing incidence of chronic diseases, such as heart disease, cancer, stroke, or diabetes, is attributed to the growing acceptance for biopharmaceuticals. For instance, According to CDC 30.3 million Americans—nearly 1 in 10—have diabetes, which in turn supports the growth of pharmaceutical and biotechnology market. High effectiveness with fewer side effects results in huge market demand for biopharmaceuticals. Further, introduction of Biologics and Biosimilars also play major role in treating diseases which enhances the growth of pharmaceutical and biotechnology market. For instance, Humira , Lantus, Amjevita etc. are different biosimilars which used for curing human diseases like rheumatoid arthritis, diabetes etc.

The major factor that restrains the pharmaceutical and biotechnology market growth is drug affordability. Moreover, the high operational costs of biotechnology and the risk associated with genetic data may also hinder the pharmaceutical and biotechnology market progress.

pharmaceutical and biotechnology market has been segmented on the basis of, product type, by therapeutic application and by region. On the basis of product type the target market can be classified as vaccines, and synthetic immune-modulators, where the vaccines is further sub-segmented into recombinant vaccines, conventional vaccines, recombinant enzymes, cell and gene therapies, and other product type, and Synthetic Immuno-modulators are sub-segmented into cytokines, interferones, interleukins and tumor necrosis factor.On the basis of therapeutic application the target market can be classified as autoimmune disorders, metabolic disorders, hormonal disorders, disease prevention, cardiovascular diseases, neurological diseases, other diseases.

On the basis of region, the pharmaceutical and biotechnology market has been segmented into North America, Europe, Asia- Pacific, Latin America, and Middle East &Africa.

Asia Pacific has overtaken Europe as the second largest region because growth in Asia Pacific is due to the increased affordability of drugs resulting from the launch of low priced generics.High growth in Asia Pacific region is attributable to increasing incidence of chronic diseases as well as innovative technologies in biotechnology sector.

Some of the competitive market share players in pharmaceutical and biotechnology market are Pfizer, Roche, Johnson-Johnson, Sanofi, Merck, Novartis, Amgen Abbott Laboratories, Agilent Technologies, Ely Lily, Biogen Scientific, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Illumina, Merck, PerkinElmer, Qiagen and Thermo Fisher Scientific.

Global Pharmaceutical And Biotechnology Market Table of Contents

Research Objective and Assumption

  • Preface
  • Research Objectives
  • Study Scope
  • Years Considered for the study
  • Assumptions
  • Abbreviations

Research Methodology

  • Research data
  • Primary Data
    • Primary Interviews
    • Primary Breakdown
    • Key data from Primary Sources
    • Key Thickness Insights
  • Secondary Data
    • Major Secondary Sources
    • Secondary Sources
  • Market Estimation
  • Top-Down Approach
    • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
  • Bottom-Up Approach
    • Approach for estimating market share by Bottom-up Analysis (Demand Side)
  • Market Breakdown and Data Triangulation
  • Research Assumptions

Market Preview

  • Executive Summary
  • Key Findings—Global Outlook for medical carts Strategies
    • Key Questions this Study will Answer
    • Market Snippet, By Product Type
    • Market Snippet, By Therapeutic Application
    • Market Snippet, By Region
  • Opportunity Map Analysis
  • Executive Summary—3 Big Predictions

Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restrains
    • Market Opportunities
    • Market Trends
  • DR Impact Analysis
  • PEST Analysis
  • Porter’s Five Forces Analysis
  • Opportunity Orbit
  • Market Investment Feasibility Index
  • Macroeconomic Factor Analysis

Market Segmentation, By Product Type, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Vaccines (Recombinant Vaccines
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Conventional Vaccines
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Recombinant Enzymes
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Cell and Gene Therapies
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Other Product Types
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Synthetic Immuno-modulators
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Cytokines
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Interferones
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Interleukins
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Tumor Necrosis Factor
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, Therapeutic Application, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Segment Trends
  • Oncology
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Inflammatory
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Infectious Diseases
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Autoimmune Disorders
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Metabolic Disorders
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Hormonal Disorders
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Disease Prevention
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Cardiovascular Diseases
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Neurological Diseases
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
  • Other Diseases
    • Overview
    • Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Global Market, By Region, Forecast Period up to 10 Years, (US$ Bn)

  • Overview
    • Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
    • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
    • Regional Trends
  • North America
    • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Therapeutic Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • U.S.
      • Canada
  • Europe
    • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Therapeutic Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • UK
      • France
      • Germany
      • Russia
      • Italy
      • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Therapeutic Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
      • India
      • Japan
      • South Korea
      • China
      • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Therapeutic Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
    • Market Size and Forecast (US$ Bn), By Product Type, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Therapeutic Application, Forecast Period up to 10 Years
    • Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East

Competitive Landscape

  • Heat Map Analysis
  • Market Presence and Specificity Analysis

Company Profiles

  • Pfizer.
    •   Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Roche
    • Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Johnson-Johnson
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Sanofi
    • Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Novartis
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Amgen Abbott Laboratories
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Agilent Technologies
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Ely Lily
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Biogen Scientific
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  •  Bio-Rad Laboratories
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Danaher
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • F. Hoffmann-La Roche
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Illumina
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Merck
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • PerkinElmer
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Qiagen 
    •  Company Overview
    • Product Type Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

The Last Word

  • Future Impact
  • About Us
  • Contact

FAQs

pharmaceutical and biotechnology market has been segmented on the basis of, product type, by therapeutic application and by region.

Emerging trends include personalized medicine, advancements in biopharmaceuticals, and increased focus on gene and cell therapies. Opportunities arise from growing demand for innovative treatments, biotechnology advancements, and global health challenges.

Key factors include the need for novel treatments and therapies, increased R&D investments, technological advancements in genomics and proteomics, and a growing aging population globally.

Regions covered include North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America is expected to dominate the market due to a concentration of major pharmaceutical and biotechnology companies, robust research infrastructure, and high healthcare expenditures.

Some of the competitive market share players in pharmaceutical and biotechnology market are Pfizer, Roche, Johnson-Johnson, Sanofi, Merck, Novartis, Amgen Abbott Laboratories, Agilent Technologies, Ely Lily, Biogen Scientific, Bio-Rad Laboratories, Danaher, F. Hoffmann-La Roche, Illumina, Merck, PerkinElmer, Qiagen and Thermo Fisher Scientific.